Cx Institutional Eli Lilly & CO Transaction History

Cx Institutional

$2.24 Billion
Q3 2024

A detailed history of Cx Institutional transactions in Eli Lilly & CO stock. As of the latest transaction made, Cx Institutional holds 19,171 shares of LLY stock, worth $14.7 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

19,171

Previous 19,579 2.08%

Holding current value

$14.7 Million

Previous $17.7 Million 4.19%

% of portfolio

0.76%

Previous 0.84%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$772.14 - $960.02 $315,033 - $391,688	-408 Reduced 2.08%	19,171 $17 Million
Q2 2024 Jul 11, 2024	SELL	$724.87 - $909.04 $684,277 - $858,133	-944 Reduced 4.6%	19,579 $17.7 Million
Q1 2024 Apr 15, 2024	BUY	$592.2 - $792.28 $846,253 - $1.13 Million	1,429 Added 7.48%	20,523 $16 Million
Q4 2023 Jan 12, 2024	SELL	$525.19 - $619.13 $1.52 Million - $1.8 Million	-2,903 Reduced 13.2%	19,094 $11.1 Million
Q3 2023 Oct 17, 2023	SELL	$434.7 - $599.3 $3.62 Million - $4.99 Million	-8,330 Reduced 27.47%	21,997 $11.8 Million
Q2 2023 Jul 26, 2023	BUY	$350.74 - $468.98 $17,537 - $23,449	50 Added 0.17%	30,327 $14.2 Million
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $4.36 Million - $5.12 Million	14,029 Added 86.34%	30,277 $10.4 Million
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $3.27 Million - $3.82 Million	10,183 Added 167.9%	16,248 $5.94 Million
Q3 2022 Nov 04, 2022	BUY	$296.48 - $337.87 $209,018 - $238,198	705 Added 13.15%	6,065 $1.96 Million
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $174,206 - $204,543	625 Added 13.2%	5,360 $1.74 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $96,692 - $120,163	412 Added 9.53%	4,735 $1.36 Million
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $19,786 - $24,555	88 Added 2.08%	4,323 $1.19 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $9,307 - $11,453	-42 Reduced 0.98%	4,235 $979,000
Q2 2021 Aug 04, 2021	SELL	$180.55 - $233.54 $1.77 Million - $2.29 Million	-9,808 Reduced 69.63%	4,277 $982,000
Q1 2021 Apr 15, 2021	BUY	$164.32 - $212.72 $550,636 - $712,824	3,351 Added 31.22%	14,085 $2.63 Million
Q4 2020 Jan 12, 2021	SELL	$130.46 - $172.63 $133,982 - $177,291	-1,027 Reduced 8.73%	10,734 $1.81 Million
Q3 2020 Oct 13, 2020	BUY	$146.22 - $169.13 $85,100 - $98,433	582 Added 5.21%	11,761 $1.74 Million
Q2 2020 Aug 06, 2020	BUY	$136.42 - $164.18 $35,469 - $42,686	260 Added 2.38%	11,179 $1.84 Million
Q1 2020 Apr 29, 2020	BUY	$119.05 - $147.35 $987,281 - $1.22 Million	8,293 Added 315.8%	10,919 $1.52 Million
Q4 2019 Jan 21, 2020	SELL	$106.92 - $132.43 $4,383 - $5,429	-41 Reduced 1.54%	2,626 $345,000
Q3 2019 Oct 10, 2019	SELL	$106.79 - $116.16 $140,749 - $153,098	-1,318 Reduced 33.07%	2,667 $298,000
Q2 2019 Jul 17, 2019	BUY	$110.79 - $129.32 $47,307 - $55,219	427 Added 12.0%	3,985 $441,000
Q1 2019 Apr 03, 2019	BUY	$111.31 - $131.02 $123,999 - $145,956	1,114 Added 45.58%	3,558 $462,000
Q4 2018 Jan 14, 2019	BUY	$105.9 - $118.64 $258,819 - $289,956	2,444 New	2,444 $283,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.

Account

Cx Institutional Eli Lilly & CO Transaction History